VENTURI CARDIOLOGY LIMITED


2022-06-012023-05-312023-05-31false12896650VENTURI CARDIOLOGY LIMITED2023-11-3086220iso4217:GBPxbrli:pure128966502022-06-01128966502023-05-31128966502022-06-012023-05-31128966502021-06-01128966502022-05-31128966502021-06-012022-05-3112896650bus:SmallEntities2022-06-012023-05-3112896650bus:AuditExempt-NoAccountantsReport2022-06-012023-05-3112896650bus:FullAccounts2022-06-012023-05-3112896650bus:PrivateLimitedCompanyLtd2022-06-012023-05-3112896650core:WithinOneYear2023-05-3112896650core:AfterOneYear2023-05-3112896650core:WithinOneYear2022-05-3112896650core:AfterOneYear2022-05-3112896650core:ShareCapital2023-05-3112896650core:SharePremium2023-05-3112896650core:RevaluationReserve2023-05-3112896650core:OtherReservesSubtotal2023-05-3112896650core:RetainedEarningsAccumulatedLosses2023-05-3112896650core:ShareCapital2022-05-3112896650core:SharePremium2022-05-3112896650core:RevaluationReserve2022-05-3112896650core:OtherReservesSubtotal2022-05-3112896650core:RetainedEarningsAccumulatedLosses2022-05-3112896650core:LandBuildings2023-05-3112896650core:PlantMachinery2023-05-3112896650core:Vehicles2023-05-3112896650core:FurnitureFittings2023-05-3112896650core:OfficeEquipment2023-05-3112896650core:NetGoodwill2023-05-3112896650core:IntangibleAssetsOtherThanGoodwill2023-05-3112896650core:ListedExchangeTraded2023-05-3112896650core:UnlistedNon-exchangeTraded2023-05-3112896650core:LandBuildings2022-05-3112896650core:PlantMachinery2022-05-3112896650core:Vehicles2022-05-3112896650core:FurnitureFittings2022-05-3112896650core:OfficeEquipment2022-05-3112896650core:NetGoodwill2022-05-3112896650core:IntangibleAssetsOtherThanGoodwill2022-05-3112896650core:ListedExchangeTraded2022-05-3112896650core:UnlistedNon-exchangeTraded2022-05-3112896650core:LandBuildings2022-06-012023-05-3112896650core:PlantMachinery2022-06-012023-05-3112896650core:Vehicles2022-06-012023-05-3112896650core:FurnitureFittings2022-06-012023-05-3112896650core:OfficeEquipment2022-06-012023-05-3112896650core:NetGoodwill2022-06-012023-05-3112896650core:IntangibleAssetsOtherThanGoodwill2022-06-012023-05-3112896650core:ListedExchangeTraded2022-06-012023-05-3112896650core:UnlistedNon-exchangeTraded2022-06-012023-05-3112896650core:MoreThanFiveYears2022-06-012023-05-3112896650core:Non-currentFinancialInstruments2023-05-3112896650core:Non-currentFinancialInstruments2022-05-3112896650dpl:CostSales2022-06-012023-05-3112896650dpl:DistributionCosts2022-06-012023-05-3112896650core:LandBuildings2022-06-012023-05-3112896650core:PlantMachinery2022-06-012023-05-3112896650core:Vehicles2022-06-012023-05-3112896650core:FurnitureFittings2022-06-012023-05-3112896650core:OfficeEquipment2022-06-012023-05-3112896650dpl:AdministrativeExpenses2022-06-012023-05-3112896650core:NetGoodwill2022-06-012023-05-3112896650core:IntangibleAssetsOtherThanGoodwill2022-06-012023-05-3112896650dpl:GroupUndertakings2022-06-012023-05-3112896650dpl:ParticipatingInterests2022-06-012023-05-3112896650dpl:GroupUndertakingscore:ListedExchangeTraded2022-06-012023-05-3112896650core:ListedExchangeTraded2022-06-012023-05-3112896650dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-06-012023-05-3112896650core:UnlistedNon-exchangeTraded2022-06-012023-05-3112896650dpl:CostSales2021-06-012022-05-3112896650dpl:DistributionCosts2021-06-012022-05-3112896650core:LandBuildings2021-06-012022-05-3112896650core:PlantMachinery2021-06-012022-05-3112896650core:Vehicles2021-06-012022-05-3112896650core:FurnitureFittings2021-06-012022-05-3112896650core:OfficeEquipment2021-06-012022-05-3112896650dpl:AdministrativeExpenses2021-06-012022-05-3112896650core:NetGoodwill2021-06-012022-05-3112896650core:IntangibleAssetsOtherThanGoodwill2021-06-012022-05-3112896650dpl:GroupUndertakings2021-06-012022-05-3112896650dpl:ParticipatingInterests2021-06-012022-05-3112896650dpl:GroupUndertakingscore:ListedExchangeTraded2021-06-012022-05-3112896650core:ListedExchangeTraded2021-06-012022-05-3112896650dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-06-012022-05-3112896650core:UnlistedNon-exchangeTraded2021-06-012022-05-3112896650core:NetGoodwill2023-05-3112896650core:IntangibleAssetsOtherThanGoodwill2023-05-3112896650core:LandBuildings2023-05-3112896650core:PlantMachinery2023-05-3112896650core:Vehicles2023-05-3112896650core:FurnitureFittings2023-05-3112896650core:OfficeEquipment2023-05-3112896650core:AfterOneYear2023-05-3112896650core:WithinOneYear2023-05-3112896650core:ListedExchangeTraded2023-05-3112896650core:UnlistedNon-exchangeTraded2023-05-3112896650core:ShareCapital2023-05-3112896650core:SharePremium2023-05-3112896650core:RevaluationReserve2023-05-3112896650core:OtherReservesSubtotal2023-05-3112896650core:RetainedEarningsAccumulatedLosses2023-05-3112896650core:NetGoodwill2022-05-3112896650core:IntangibleAssetsOtherThanGoodwill2022-05-3112896650core:LandBuildings2022-05-3112896650core:PlantMachinery2022-05-3112896650core:Vehicles2022-05-3112896650core:FurnitureFittings2022-05-3112896650core:OfficeEquipment2022-05-3112896650core:AfterOneYear2022-05-3112896650core:WithinOneYear2022-05-3112896650core:ListedExchangeTraded2022-05-3112896650core:UnlistedNon-exchangeTraded2022-05-3112896650core:ShareCapital2022-05-3112896650core:SharePremium2022-05-3112896650core:RevaluationReserve2022-05-3112896650core:OtherReservesSubtotal2022-05-3112896650core:RetainedEarningsAccumulatedLosses2022-05-3112896650core:NetGoodwill2021-06-0112896650core:IntangibleAssetsOtherThanGoodwill2021-06-0112896650core:LandBuildings2021-06-0112896650core:PlantMachinery2021-06-0112896650core:Vehicles2021-06-0112896650core:FurnitureFittings2021-06-0112896650core:OfficeEquipment2021-06-0112896650core:AfterOneYear2021-06-0112896650core:WithinOneYear2021-06-0112896650core:ListedExchangeTraded2021-06-0112896650core:UnlistedNon-exchangeTraded2021-06-0112896650core:ShareCapital2021-06-0112896650core:SharePremium2021-06-0112896650core:RevaluationReserve2021-06-0112896650core:OtherReservesSubtotal2021-06-0112896650core:RetainedEarningsAccumulatedLosses2021-06-0112896650core:AfterOneYear2022-06-012023-05-3112896650core:WithinOneYear2022-06-012023-05-3112896650core:Non-currentFinancialInstrumentscore:CostValuation2022-06-012023-05-3112896650core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-06-012023-05-3112896650core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-06-012023-05-3112896650core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-06-012023-05-3112896650core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-06-012023-05-3112896650core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-06-012023-05-3112896650core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-06-012023-05-3112896650core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-06-012023-05-3112896650core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-06-012023-05-3112896650core:Non-currentFinancialInstrumentscore:CostValuation2023-05-3112896650core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-3112896650core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-3112896650core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-3112896650core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-3112896650core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-3112896650core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-3112896650core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-3112896650core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-3112896650core:Non-currentFinancialInstrumentscore:CostValuation2022-05-3112896650core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-05-3112896650core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-05-3112896650core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-05-3112896650core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-05-3112896650core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-05-3112896650core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-05-3112896650core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-05-3112896650core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-05-3112896650bus:Director12022-06-012023-05-3112896650bus:Director22022-06-012023-05-3112896650bus:Director32022-06-012023-05-3112896650bus:Director42022-06-012023-05-3112896650bus:Director52022-06-012023-05-3112896650core:FurnitureFittingsToolsEquipment2022-05-3112896650core:FurnitureFittingsToolsEquipment2023-05-3112896650core:FurnitureFittingsToolsEquipment2022-06-012023-05-31

VENTURI CARDIOLOGY LIMITED

Registered Number
12896650
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2023

VENTURI CARDIOLOGY LIMITED
Company Information
for the year from 1 June 2022 to 31 May 2023

Directors

DUFFY, James Oliver
MURRAY, Scott, Dr
RAMAMOORTHY, Brian Vikram
SKLUT, Avi David
SPRINGER, Klaus Peter

Registered Address

6 Commer House
Tadcaster
Leeds
LS24 9JF

Registered Number

12896650 (England and Wales)
VENTURI CARDIOLOGY LIMITED
Balance Sheet as at
31 May 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets5747,969844,831
747,969844,831
Current assets
Debtors7182,36970,207
Cash at bank and on hand52,45316,754
234,82286,961
Creditors amounts falling due within one year8(151,921)(68,613)
Net current assets (liabilities)82,90118,348
Total assets less current liabilities830,870863,179
Creditors amounts falling due after one year9(1,500,791)(1,295,177)
Net assets(669,921)(431,998)
Capital and reserves
Called up share capital100100
Share premium99,90099,900
Profit and loss account(769,921)(531,998)
Shareholders' funds(669,921)(431,998)
  • The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  • These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime. The directors have chosen to not file a copy of the company’s profit and loss account.
The financial statements were approved and authorised for issue by the Board of Directors on 30 November 2023, and are signed on its behalf by:
MURRAY, Scott, Dr
Director
Registered Company No. 12896650
VENTURI CARDIOLOGY LIMITED
Notes to the Financial Statements
for the year ended 31 May 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Property, plant and equipment policy
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Leases policy
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Employee benefits policy
Contributions to defined contribution plans are expensed in the period to which they relate.
4.Employee information

20232022
Average number of employees during the year55
5.Property, plant and equipment

Plant & machinery

Fixtures & fittings

Total

£££
Cost or valuation
At 01 June 22857,83775,009932,846
At 31 May 23857,83775,009932,846
Depreciation and impairment
At 01 June 2281,1556,86088,015
Charge for year89,3617,50196,862
At 31 May 23170,51614,361184,877
Net book value
At 31 May 23687,32160,648747,969
At 31 May 22776,68268,149844,831
6.Description of nature of transactions and balances with related parties
Interpro Global Pte Ltd: The company is related to Interpro Global Pte Ltd by virtue of its ownership of the company's shares. The amount owed to Interpro Global Pte Ltd at the balance sheet date was £1,197,416 (2022: £994,889).
7.Debtors

2023

2022

££
Trade debtors / trade receivables111,82562,107
Prepayments and accrued income13,2378,100
Other debtors (Non-current)57,307-
Total182,36970,207
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
8.Creditors within one year

2023

2022

££
Trade creditors / trade payables83,25264,929
Finance lease and HP contracts57,307-
Accrued liabilities and deferred income11,3623,684
Total151,92168,613
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
9.Creditors after one year

2023

2022

££
Bank borrowings and overdrafts1,338,6901,083,070
Other creditors162,101212,107
Total1,500,7911,295,177
10.Finance lease and HP contracts after one year

2023

2022

££
Finance lease and HP contracts162,102212,106